If this SPL incorporates inactivated NDCs stated because of the FDA initiated compliance motion, they will be specified as such. Corticosteroids. Barbiturates appear to reinforce the metabolism of exogenous corticosteroids, most likely in the induction of hepatic microsomal enzymes. Barbiturat